Around the Web – Original Source: www.uncoverdc.com
Despite a growing effort to spread the word about the lethality of hospital COVID-19 protocols—which are still in place today—the controversial medicine Remdesivir remains the only antiviral drug approved by the U.S. Food and Drug Administration to treat COVID-19 for hospitalized patients. What is driving these contentious treatment protocols, which incorporate death-inducing Remdesivir? With the Biden administration’s public health emergency still in place, a coalition of advocates is exclaiming, “follow the money.”
With money flowing in from the CARES Act (Coronavirus Aid, Relief, and Economic Security), it is a logical assumption that financial incentives from the government are a […]
Around the Web – Original Source: www.uncoverdc.com
